Jan Alenfall
New data strengthens Follicum's diabetes project
Follicum, which develops tissue repair peptides, has taken further steps in its preclinical work to develop a drug candidate...
All patients have completed treatment in Follicum's phase IIa study
For Follicum, one of the big events of the year is coming...
Follicum one step closer to Phase III in 2021
Follicum has had a productive year that culminates...
Follicum's CEO comments on the private placement of SEK 37 million
Last week it was announced that the biotechnology company Follicum is conducting...
BioStock Studio: Follicum aims for partnership
When Follicum CEO Jan Alenfall visited BioStock's studio...
Follicum completes patient recruitment in hair study
People affected by alopecia only have one...
Follicum reaches milestone in hair study
Yesterday it was announced that Follicum has now recruited over...
New patent announcement rounds off eventful six months for Follicum
During the first half of 2020, Follicum has begun...
Follicum represents R&D at MVA's diabetes webinars
World-leading diabetes experts and prominent representatives of the Öresund Region's R&D...
BioStock studio: Follicum resumes hair study
In March, Follicum was forced to pause recruitment for its...
Hair loss has psychosocial consequences
Hair loss is a benign condition with limited physical...
Follicum's CEO comments on study approval and Vinnova grant
The topical preparation of FOL-005, Follicum's candidate for...
Notes
Mentice consolidates operations to Denver
Bio-Works secures million-dollar order from global pharmaceutical company
OncoZenge receives investment proceeds from Yangtian Bio-Pharmaceutical
Xspray Pharma confirms bioequivalence for XS003
Evaxion converts debt of EUR 3,5 million
NEWSLETTER
NEWS
AI-designed proteins are created in seconds
The price of Leqembi needs to be lowered in Japan
Merck gears up in lung diseases with giant acquisition
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The market is taking Trump's tariff threat in stride
The EU's new life science strategy – a step in the right direction or just fluff?
